Luye Pharma Group Ltd. (HKG:2186)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.970
+0.020 (1.03%)
May 12, 2025, 4:08 PM HKT

Luye Pharma Group Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
471.89532.61604.81-134.39706.59
Upgrade
Depreciation & Amortization
783.39693.73663.46577506.27
Upgrade
Other Amortization
7.288.127.864.996.35
Upgrade
Loss (Gain) From Sale of Assets
-18.49-1.50.21-11.36-0.09
Upgrade
Asset Writedown & Restructuring Costs
--11.47--
Upgrade
Loss (Gain) From Sale of Investments
-1.79-1.94-1.5514.813.46
Upgrade
Loss (Gain) on Equity Investments
0.77-0.79-0.83-10.27-1.73
Upgrade
Stock-Based Compensation
21.520.6425.4549.9850.9
Upgrade
Other Operating Activities
136.97-53.3723.14109.7162.02
Upgrade
Change in Accounts Receivable
-424.88-570.84-18.77-211.76145
Upgrade
Change in Inventory
-84.03-54.92-26.6-134.044.88
Upgrade
Change in Accounts Payable
-77.89207.24-10.9543.64144.21
Upgrade
Change in Unearned Revenue
9.97-74.87-42.47-6.43-16.86
Upgrade
Change in Other Net Operating Assets
-656.92891.38418.57-109.49-577.56
Upgrade
Operating Cash Flow
167.761,5951,654182.371,033
Upgrade
Operating Cash Flow Growth
-89.48%-3.53%806.83%-82.35%-27.36%
Upgrade
Capital Expenditures
-594.07-632.66-655.68-556.2-692.81
Upgrade
Sale of Property, Plant & Equipment
7.443.175.6613.772.31
Upgrade
Divestitures
-0.02----
Upgrade
Sale (Purchase) of Intangibles
-1,113-532.61-507.68-985.4-732.03
Upgrade
Investment in Securities
536.35-511.14-675.93-2,0571,295
Upgrade
Other Investing Activities
162.36254.97175.32148.46266.1
Upgrade
Investing Cash Flow
-1,471-1,418-1,658-3,436138.2
Upgrade
Short-Term Debt Issued
-4.9610.1--
Upgrade
Long-Term Debt Issued
10,1198,0777,6567,1557,353
Upgrade
Total Debt Issued
10,1198,0827,6667,1557,353
Upgrade
Short-Term Debt Repaid
--15.06---
Upgrade
Long-Term Debt Repaid
-8,263-8,555-8,323-7,561-5,913
Upgrade
Total Debt Repaid
-8,263-8,570-8,323-7,561-5,913
Upgrade
Net Debt Issued (Repaid)
1,856-488.07-656.23-406.321,440
Upgrade
Issuance of Common Stock
-922.97-1,044-
Upgrade
Repurchase of Common Stock
-----77.96
Upgrade
Common Dividends Paid
-----175.49
Upgrade
Other Financing Activities
1,101406.7710.381,241-932.61
Upgrade
Financing Cash Flow
2,956841.654.151,879253.98
Upgrade
Foreign Exchange Rate Adjustments
45.41-103.6-164.15-52.37112.41
Upgrade
Net Cash Flow
1,698915.23-114.51-1,4271,538
Upgrade
Free Cash Flow
-426.31962.83998.11-373.83340.64
Upgrade
Free Cash Flow Growth
--3.54%---19.53%
Upgrade
Free Cash Flow Margin
-7.03%15.67%16.69%-7.19%6.15%
Upgrade
Free Cash Flow Per Share
-0.110.260.29-0.110.11
Upgrade
Cash Interest Paid
450.1471.51369.2297.12330.36
Upgrade
Cash Income Tax Paid
206.93132.2392.77270.74160.41
Upgrade
Levered Free Cash Flow
-2,501629.06-43-778.54499.72
Upgrade
Unlevered Free Cash Flow
-2,1501,051251.85-528.88763
Upgrade
Change in Net Working Capital
1,966-939.34-225.24-153.53-1,008
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.